Press Releases Aurobindo Pharma

Equities

Market Closed - NSE India S.E. Other stock markets 07:43:52 2024-06-12 am EDT			5-day change	1st Jan Change
1,249 ^INR	-0.64%		+4.31%	+15.22%

Jun. 05	Hindalco-owned Novelis delays US IPO; shares slide	RE
May. 27	Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit	MT

Aurobindo Pharma : receives USFDA Approval for Mometasone Furoate Monohydrate Nasal Spray	May. 31	PU
Aurobindo Pharma : PR Q4 FY 2023 24	May. 25	PU
Aurobindo Pharma : Q4FY24	May. 17	PU
Maintainability Of Sister Ship Arrest On The Premise That Both Vessels Are Managed/operated By The Same Entity, While Each Ship Is Owned By Distinct One Ship Company – Bombay High Court	Apr. 29	AQ
Aurobindo Pharma : Q2 – UFR 2023-24	Nov. 08	PU
Aurobindo Pharma : Q2FY24	23-10-31	PU
Aurobindo Pharma : PR-Q1 FY 2023-24	23-08-14	PU
Aurobindo Pharma : Earnings Presentation-Q1 FY 2023-24	23-08-14	PU
Aurobindo Pharma : Q1 – UFR 2023-24	23-08-14	PU
Aurobindo Pharma : Annual CSR Report 2022-23	23-08-08	PU
Aurobindo Pharma : Q1FY24	23-08-04	PU
Aurobindo Pharma : Annual Report 2022-23	23-08-02	PU
Aurobindo Pharma : Q4 – AFR 2022-23	23-05-26	PU
Aurobindo Pharma : Q4FY23	23-05-19	PU
Aurobindo Pharma : Earnings Presentation-Q3 FY 2022-23	23-02-09	PU
Aurobindo Pharma : Q3FY23	23-02-03	PU
Aurobindo Receives FDA Approval for Emzahh 0.35mg	23-01-11	AQ
Aurobindo Receives FDA Approval for Ursodiol Capsules USP, 300mg	22-12-01	AQ
Aurobindo Receives FDA Approval for Carbidopa and Levodopa Tablets	22-11-30	AQ
Aurobindo Pharma : Earnings Presentation-Q2 FY 2022-23	22-11-14	PU

No results for this search